Know Labs Publishes Study on Non-Invasive Diabetes Screening Device
Know Labs Publishes Study on Non-Invasive Diabetes Screening Device
Know Labs发布了关于非侵入性糖尿病筛查设备的研究。
Know Labs, Inc. (NYSE:KNW), a leading developer of non-invasive medical diagnostic technology, today announced the publication of its peer-reviewed study in Diabetes Technology & Therapeutics Journal titled, "A Glycemic Status Classification Model Using a Radiofrequency Noninvasive Blood Glucose Monitor." Diabetes Technology & Therapeutics is a leading, peer-reviewed journal covering all aspects of diagnosing and managing diabetes with cutting-edge devices, drugs, drug delivery systems, and software.
今天，非侵入式医学诊断技术领先开发商Know Labs, Inc. (NYSE:KNW)宣布，在以刊物Diabetes Technology & Therapeutics为题的评审研究中，发表了题为“A Glycemic Status Classification Model Using a Radiofrequency Noninvasive Blood Glucose Monitor.” 的同行评审研究。Diabetes Technology & Therapeutics 是一本领先、同行评审的期刊，涵盖了利用尖端设备、药品、药品输送系统和软件诊断和管理糖尿病的所有方面。
The published clinical research results demonstrate that Know Labs' proprietary non-invasive radiofrequency (RF) dielectric sensor and trade-secret machine learning (ML) algorithms correctly classified an individual's glycemic status...
已发表的临床研究结果表明，Know Labs的专有非侵入式射...
登录免费看全文
登录/注册